Recent events
Recent events tied to this brand in public sources.
Back to profile5 entries
2021
Medable announces $78 million in funding
Medable announced $78 million in new funding, led by Sapphire Ventures, with participation from Obvious Ventures and follow-on investment from existing investors.
2020
PPD and Lupus Therapeutics collaborate on lupus clinical research
PPD and Lupus Therapeutics are collaborating on lupus clinical research. The collaboration is intended to expand and enhance research for PPD’s pharmaceutical and biotech customers, and the article describes access to Lupus Clinical Investigators Network research sites and investigators.
2020
PPD begins trading on Nasdaq
PPD began trading on the Nasdaq Global Select Market under the symbol PPD, returning to public-company status. Its shares opened at $31 per share.
2020
Bitty & Beau’s Coffee opens location at PPD
PPD and Bitty & Beau’s Coffee partnered to establish a Bitty & Beau’s location within PPD, with the stated aim of providing more opportunities for workers with disabilities and promoting inclusion.
2020
PPD files for IPO
PPD filed with the SEC for an initial public offering to raise up to $100 million.